Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02974569 · ClinicalTrials.gov registry record
Improving Symptom Self-management in Adolescents & Young Adults With Cancer
A clinical trial of Cancer and Symptom Clusters, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 30
- Enrollment target
- 2
- Study locations
NCT02974569: Completed study of Cancer and Symptom Clusters, sponsored by Virginia Commonwealth University.
NCT02974569 is a study of Cancer and Symptom Clusters that has completed, run by Virginia Commonwealth University. The registered enrollment target is 30 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02974569, a study of Cancer and Symptom Clusters, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study evaluates the use of the Computerized Symptom Capture Tool (C-SCAT), which creates an image of the symptoms the participant is experiencing, for improving symptom self-management in adolescents and young adults with cancer. In this one-group trial, participants will complete the C-SCAT and use it during two clinic visits with their oncology providers.
Conditions Studied
Interventions
- DEVICE Computer Symptom Capture Tool
Study Locations (2)
Missouri
- The Childrens Mercy Hospital - Kansas City
Virginia
- Virginia Commonwealth University/Massey Cancer Center - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-11-01 |
| Est. Completion | 2017-10-25 |
What the finished NCT02974569 record still lists
NCT02974569 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Computer Symptom Capture Tool is the first listed.
NCT02974569 reports a single indexed study location in Missouri, Virginia.
Frequently Asked Questions
What is clinical trial NCT02974569 about?
NCT02974569 is a clinical study titled "Improving Symptom Self-management in Adolescents & Young Adults With Cancer". This study evaluates the use of the Computerized Symptom Capture Tool (C-SCAT), which creates an image of the symptoms the participant is experiencing, for improving symptom self-management in adolescents and young adults with cancer. In this one-group trial, participants will complete the C-SCAT an...
What is the current status of trial NCT02974569?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-11-01. Estimated completion is 2017-10-25.
What conditions does trial NCT02974569 study?
This clinical trial studies the following conditions: Cancer, Symptom Clusters.
What interventions are being tested in trial NCT02974569?
The interventions under investigation include: Computer Symptom Capture Tool (DEVICE).
Who is sponsoring clinical trial NCT02974569?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02974569 being conducted?
This trial has 2 study locations across Missouri, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02974569's enrollment target sits among peer trials
30 502nd of 615 higher than 93 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI